Company Filing History:
Years Active: 1999-2006
Title: The Innovative Contributions of Peter C Roberts
Introduction
Peter C Roberts is a notable inventor based in Holliston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides for medical applications. With a total of 6 patents, his work has had a profound impact on the treatment of viral infections.
Latest Patents
One of his latest patents is titled "Oligonucleotides specific for hepatitis B virus." This invention discloses synthetic oligonucleotides that are complementary to both contiguous and noncontiguous regions of the HBV RNA. The patent also includes methods and kits designed to inhibit the replication and expression of HBV, as well as to treat HBV infections and associated conditions. Another significant patent is "Transplacental delivery of oligonucleotides." This invention provides synthetic oligonucleotides that are useful for transplacental delivery. The oligonucleotides can be DNA or RNA, preferably ranging from 12 to 35 nucleotides in length, and feature a stabilized and charged backbone along with at least one chemically modified base or sugar moiety to facilitate transplacental delivery.
Career Highlights
Throughout his career, Peter has worked with various companies, including Hybridon, Inc. and Quantitative Informational Knockout Technology. His innovative work in these organizations has contributed to advancements in genetic research and therapeutic applications.
Collaborations
Peter has collaborated with notable individuals in his field, including Bruce L Frank and John S Mills. These partnerships have further enhanced the scope and impact of his inventions.
Conclusion
Peter C Roberts is a distinguished inventor whose work in biotechnology has led to important advancements in the treatment of viral infections. His patents reflect a commitment to innovation and a desire to improve medical outcomes for patients.